Cardiotoxicity From Human Epidermal Growth Factor Receptor-2 (HER2) Targeted Therapies

被引:7
作者
Florido, Roberta [1 ]
Smith, Karen L. [2 ]
Cuomo, Kimberly K. [1 ]
Russell, Stuart D. [1 ]
机构
[1] Johns Hopkins Univ, Div Cardiol, 1800 Orleans St,Zayed 7125, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, Breast & Ovarian Canc Program, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2017年 / 6卷 / 09期
关键词
breast cancer; cardiotoxicity; heart failure; human epidermal growth factor-2; trastuzumab;
D O I
10.1161/JAHA.117.006915
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:14
相关论文
共 101 条
[1]   Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial [J].
Advani, Pooja P. ;
Ballman, Karla V. ;
Dockter, Travis J. ;
Colon-Otero, Gerardo ;
Perez, Edith A. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (06) :581-+
[2]  
[Anonymous], 2015, Breast Cancer Facts Figures 2015-2016
[3]   Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline [J].
Armenian, Saro H. ;
Lacchetti, Christina ;
Barac, Ana ;
Carver, Joseph ;
Constine, Louis S. ;
Denduluri, Neelima ;
Dent, Susan ;
Douglas, Pamela S. ;
Durand, Jean-Bernard ;
Ewer, Michael ;
Fabian, Carol ;
Hudson, Melissa ;
Jessup, Mariell ;
Jones, Lee W. ;
Ky, Bonnie ;
Mayer, Erica L. ;
Moslehi, Javid ;
Oeffinger, Kevin ;
Ray, Katharine ;
Ruddy, Kathryn ;
Lenihan, Daniel .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08) :893-U144
[4]   Screening Adult Survivors of Childhood Cancer for Cardiomyopathy: Comparison of Echocardiography and Cardiac Magnetic Resonance Imaging [J].
Armstrong, Gregory T. ;
Plana, Juan Carlos ;
Zhang, Nan ;
Srivastava, Deokumar ;
Green, Daniel M. ;
Ness, Kirsten K. ;
Donovan, F. Daniel ;
Metzger, Monika L. ;
Arevalo, Alejandro ;
Durand, Jean-Bernard ;
Joshi, Vijaya ;
Hudson, Melissa M. ;
Robison, Leslie L. ;
Flamm, Scott D. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (23) :2876-2884
[5]   ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics [J].
Arteaga, Carlos L. ;
Engelman, Jeffrey A. .
CANCER CELL, 2014, 25 (03) :282-303
[6]   Trastuzumab-containing regimens for metastatic breast cancer [J].
Balduzzi, Sara ;
Mantarro, Stefania ;
Guarneri, Valentina ;
Tagliabue, Ludovica ;
Pistotti, Vanna ;
Moja, Lorenzo ;
D'Amico, Roberto .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (06)
[7]   Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast [J].
Baselga, J ;
Tripathy, D ;
Mendelsohn, J ;
Baughman, S ;
Benz, CC ;
Dantis, L ;
Sklarin, NT ;
Seidman, AD ;
Hudis, CA ;
Moore, J ;
Rosen, PP ;
Twaddell, T ;
Henderson, IC ;
Norton, L .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :737-744
[8]   Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer [J].
Baselga, Jose ;
Cortes, Javier ;
Kim, Sung-Bae ;
Im, Seock-Ah ;
Hegg, Roberto ;
Im, Young-Hyuck ;
Roman, Laslo ;
Pedrini, Jose Luiz ;
Pienkowski, Tadeusz ;
Knott, Adam ;
Clark, Emma ;
Benyunes, Mark C. ;
Ross, Graham ;
Swain, Sandra M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (02) :109-119
[9]   Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance - Are they interchangeable? [J].
Bellenger, NG ;
Burgess, MI ;
Ray, SG ;
Lahiri, A ;
Coats, AJS ;
Cleland, JGF ;
Pennell, DJ .
EUROPEAN HEART JOURNAL, 2000, 21 (16) :1387-1396
[10]   Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer [J].
Blackwell, Kimberly L. ;
Burstein, Harold J. ;
Storniolo, Anna Maria ;
Rugo, Hope ;
Sledge, George ;
Koehler, Maria ;
Ellis, Catherine ;
Casey, Michelle ;
Vukelja, Svetislava ;
Bischoff, Joachim ;
Baselga, Jose ;
O'Shaughnessy, Joyce .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) :1124-1130